Remove Compounding Remove Medical Schools Remove Pharmacy Management
article thumbnail

Semaglutide and Tirzepatide Lead the Way in Comprehensive Diabetes and Obesity Management

Pharmacy Times

Beyond glycemic control: integrating GLP-1 agonists into comprehensive diabetes management. Presented at: Pharmacy Times Clinical Forum; June 12, 2025; Boston, MA. UMass Chan Medical School. Banting & Best: the discovery of insulin. Accessed June 25, 2025. N Engl J Med. 2024;391(2):109-121.

article thumbnail

Navigating EGFR Mutations and ALK Fusions in Early-Stage Non-Small Cell Lung Cancer

Pharmacy Times

Perioperative treatment should be tailored today based on individual clinical and genomic features for patients with EGFR - and ALK -type [NSCLC],” concluded Biagio Ricciuti, MD, PhD, from the Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School.